A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- N/A
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
- Status
- COMPLETED
- Phase
- N/A
CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Expanded Access for Anti-IL8
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access for Apixaban
- Status
- AVAILABLE
- Phase
- N/A
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access for Abatacept
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access for Relatlimab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Status
- RECRUITING
- Phase
- N/A
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1